Overview: Sun Pharma leads the sector with the highest market capitalization and strong investor confidence.Mankind Pharma ...
SoftBank Group is expected by analysts to report another robust quarterly profit on Wednesday as the technology investor ...
Life360 reports 1Q26 revenue growth of 38% to $143.1m, advertising revenue up 329% to $19.7m, adjusted EBITDA of $17.1m vs.
The U.S.-Iran conflict, now in its third month, has torn through global oil supply at a historic pace. Yet prices at the pump ...
Trump rejected Iran's latest peace proposal as "TOTALLY UNACCEPTABLE" Sunday after Tehran sent fresh drone attacks at UAE, ...
The clinical-stage biotech is focused on psychedelic-assisted therapies for mental health conditions, particularly ...
Investor's Business Daily on MSN
Why these four biotech stocks prove that follow-on entries still pop up in stock market leaders
AnaptysBio recorded $234 million in sales over the past four quarters.
Biopharmaceutical company Odyssey Therapeutics has raised $279 million in its upsized U.S. initial public offering, the ...
4don MSNOpinion
Alpha buying: Insider conviction in high-risk biotech
Insider buying matters in every industry, but it carries a special weight in biotechnology. In most businesses, management ...
Super investors are shifting focus to niche healthcare segments like fertility, CDMO and oncology, signalling rising interest ...
The key indices, Sensex and Nifty 50, ended lower on 5 May, driven by profit-taking. Mid- and small-cap stocks showed gains.
If you have ideas for Eye on Patents columns, pleases email me, Michael McCoy, C&EN’s business editor, at m_mccoy@acs.org.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results